NONOF NOVO NORDISK A S
Price Chart
Executive Summary
Novo Nordisk filed a 6-K to report ongoing share repurchase activity under a pre-announced program. Since 4 February 2026, the company has repurchased 17,049,028 B shares at an average price of DKK 262.22 for a total value of DKK 4.47 billion, as part of a DKK 15 billion program. The filing is a routine operational update on capital allocation with no material financial data, guidance changes, or strategic announcements.
Actionable Insight
The repurchase program is routine and pre-announced. No new strategic or financial signals — monitor next earnings release for fundamental trends and guidance updates.
Key Facts
- Novo Nordisk has repurchased 17,049,028 B shares at an average price of DKK 262.22 per share since 4 February 2026 for a total of DKK 4,470,560,295.
- The overall buyback program allows for up to DKK 15 billion in repurchases over a 12-month period ending 1 February 2027.
- As of 22 May 2026, the company holds 34,234,329 B shares as treasury shares, representing 0.8% of total share capital.
- No financial results, guidance updates, or material operational changes were reported in this filing.
Financial Impact
DKK 4.47 billion repurchased so far vs. DKK 15 billion authorization
Risk Factors
- Competition in obesity/diabetes market could pressure growth
- Upcoming semaglutide loss of exclusivity in certain markets
- Workforce reduction and restructuring overhang
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001171843-26-003710 |
| Document: 0001171843-26-003710-index-headers.html | 0001171843-26-003710 |
| Document: 0001171843-26-003710-index.html | 0001171843-26-003710 |
| Document: 0001171843-26-003710.txt | 0001171843-26-003710 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 27, 2026
10d ago
|
6-K
| — | awaiting T+5 | — | — |
|
May 22, 2026
15d ago
|
6-K
| $43.80 $44.29 | ▲ +1.12% | ▼ −0.54% | $43.36 (−1.00%) |
|
Apr 13, 2026
7w ago
|
6-K
| $38.08 $39.71 | ▲ +4.28% | ▲ +0.98% | $43.36 (+13.87%) |
|
Apr 7, 2026
8w ago
|
6-K
| $35.92 $38.82 | ▲ +8.07% | ▲ +2.74% | $43.36 (+20.71%) |
|
Mar 27, 2026
10w ago
|
6-K
| $35.29 $35.58 | ▲ +0.82% | ▼ −3.04% | $43.36 (+22.87%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access